Lafutin Tablets (Lafutidine)

Adult dose

1. Short-term treatment of gastric ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. In clinical trials of up to 8 weeks, most ulcers healed within 8 weeks, although healing time may vary between patients. 2. Short-term treatment of duodenal ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. In clinical trials of up to 6 weeks, most ulcers healed within 6 weeks, although healing time may vary between patients. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is 10mg of lafutidine orally once daily before bedtime. In clinical trials of up to 2 weeks, most lesions healed within 2 weeks, although healing time may vary between patients. 4. Combination antibiotic therapy for patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 days or 14 days. 5. Premedication before anesthesia: The usual dose is 10mg of lafutidine per administration, given orally twice (before bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10mg of lafutidine per dose orally twice daily.

This medication should not be used by individuals who are allergic to its components. It contains lactose, so individuals with lactose intolerance or certain genetic disorders should avoid using it. Patients with a history of drug allergies, liver or kidney function problems, patients undergoing dialysis, and older adults should use this medication with caution. Severe allergic reactions may occur during treatment with this medication, so if symptoms such as pallor, hypotension, or difficulty breathing appear, stop taking the medication immediately and seek medical help. Liver function may be impaired, so regular liver function tests should be performed, and if any issues arise, the medication should be discontinued. Side effects such as decreased blood cell counts may occur; if symptoms like throat pain, lethargy, or fever occur, consult a physician. Rarely, side effects affecting the heart or nervous system have been reported, so any unusual symptoms should be reported immediately. Various side effects can occur in the gastrointestinal system, central nervous system, circulatory system, blood system, liver, kidneys, etc., so if symptoms persist or worsen, consult a healthcare professional. In particular, if stomach cancer or malignant tumors are suspected, regular examinations should be conducted as this medication may mask symptoms or delay diagnosis. Older adults may have decreased physical function, so dosage and administration intervals should be carefully adjusted and monitored. Patients undergoing dialysis may have increased drug concentrations, so starting with a low dose and careful administration is required. Pregnant women should only use it when necessary and under the advice of a doctor, and breastfeeding women should avoid taking this medication as it may pass into breast milk. Safety in pediatric patients is not well established, so caution is necessary when using this medication. This medication should be stored out of the reach of children and preferably kept in its original container for safety.

• Shock
• symptoms of anaphylaxis
• facial pallor
• hypotension
• generalized rash
• shortness of breath
• liver dysfunction
• jaundice
• agranulocytosis
• pharyngitis

This medication should be stored in a tightly sealed container to avoid exposure to air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. This helps ensure the medication's efficacy is preserved safely.

Appearance

White, round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle